Ramtin Agah

CIK: 0001862617

Transaction Breakdown

Open Market Buys (P)12 (75.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (18.8%)

Compensation grants

Other (G, F, J, C, D, …)1 (6.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RNXT

RenovoRx, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (16 total)

RNXT
RenovoRx, Inc.
Apr 3, 2026
Award(A)
Stock Option
Direct
621.7K shares-
RNXT
RenovoRx, Inc.
Jan 21, 2026
Purchase(P)
Direct
10K shares at avg. $1.00$10K
RNXT
RenovoRx, Inc.
Dec 31, 2025
Purchase(P)
Direct
9.8K shares at avg. $0.86$8K
RNXT
RenovoRx, Inc.
Dec 30, 2025
Purchase(P)
Direct
205 shares at avg. $0.83$169.33
RNXT
RenovoRx, Inc.
Dec 16, 2025
Purchase(P)
Direct
12K shares at avg. $0.85$10K
RNXT
RenovoRx, Inc.
Dec 5, 2025
Purchase(P)
Direct
10K shares at avg. $0.96$10K
RNXT
RenovoRx, Inc.
Nov 24, 2025
Purchase(P)
Direct
12K shares at avg. $0.80$10K
RNXT
RenovoRx, Inc.
Nov 21, 2025
Purchase(P)
Direct
10K shares at avg. $0.80$8K
RNXT
RenovoRx, Inc.
Jul 1, 2025
Award(A)
Stock Option
Direct
63.6K shares-
RNXT
RenovoRx, Inc.
Jun 5, 2025
Purchase(P)
Direct
21K shares at avg. $1.40$29K
RNXT
RenovoRx, Inc.
Apr 22, 2025
Gift(G)
Direct
400K shares-
RNXT
RenovoRx, Inc.
Apr 15, 2025
Purchase(P)
Direct
15K shares at avg. $0.90$14K
RNXT
RenovoRx, Inc.
Apr 14, 2025
Award(A)
Stock Option
Direct
254.5K shares-
RNXT
RenovoRx, Inc.
Apr 11, 2025
Purchase(P)
Direct
20K shares at avg. $0.80$16K
RNXT
RenovoRx, Inc.
Apr 9, 2025
Purchase(P)
Direct
30K shares at avg. $0.81$24K
RNXT
RenovoRx, Inc.
Apr 8, 2025
Purchase(P)
Direct
26K shares at avg. $0.84$22K

		Type	Shares	Price		Ownership
Apr 3, 2026	RNXT RenovoRx, Inc.	Award(A) Stock Option	621,727	-	-	Direct
Jan 21, 2026	RNXT RenovoRx, Inc.	Purchase(P)	10,000	$1.00	$9,975	Direct
Dec 31, 2025	RNXT RenovoRx, Inc.	Purchase(P)	9,795	$0.86	$8,424	Direct
Dec 30, 2025	RNXT RenovoRx, Inc.	Purchase(P)	205	$0.83	$169	Direct
Dec 16, 2025	RNXT RenovoRx, Inc.	Purchase(P)	12,000	$0.85	$10,200	Direct
Dec 5, 2025	RNXT RenovoRx, Inc.	Purchase(P)	10,000	$0.96	$9,600	Direct
Nov 24, 2025	RNXT RenovoRx, Inc.	Purchase(P)	12,000	$0.80	$9,600	Direct
Nov 21, 2025	RNXT RenovoRx, Inc.	Purchase(P)	10,000	$0.80	$8,000	Direct
Jul 1, 2025	RNXT RenovoRx, Inc.	Award(A) Stock Option	63,636	-	-	Direct
Jun 5, 2025	RNXT RenovoRx, Inc.	Purchase(P)	21,000	$1.40	$29,400	Direct
Apr 22, 2025	RNXT RenovoRx, Inc.	Gift(G)	400,000	-	-	Direct
Apr 15, 2025	RNXT RenovoRx, Inc.	Purchase(P)	15,000	$0.90	$13,500	Direct
Apr 14, 2025	RNXT RenovoRx, Inc.	Award(A) Stock Option	254,542	-	-	Direct
Apr 11, 2025	RNXT RenovoRx, Inc.	Purchase(P)	20,000	$0.80	$16,000	Direct
Apr 9, 2025	RNXT RenovoRx, Inc.	Purchase(P)	30,000	$0.81	$24,399	Direct
Apr 8, 2025	RNXT RenovoRx, Inc.	Purchase(P)	26,000	$0.84	$21,840	Direct

1-16 of 16 transactions

About Agah Ramtin

Agah Ramtin (SEC CIK 0001862617) files insider reports with the SEC as Chief Medical Officer of RenovoRx, Inc. (RNXT).

Signal8 holds 15 ownership filings by Agah Ramtin, all Form 4s, filed between Apr 9, 2025 and Apr 7, 2026. Those filings report 16 transactions, from Apr 8, 2025 to Apr 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Agah Ramtin's filings is in MOUNTAIN VIEW, CA.

Recent filings by Agah Ramtin

Apr 3, 2026: Grant or award of RNXT derivative securities (Form 4, code A).
Jan 21, 2026: Open-market purchase of RNXT shares (Form 4, code P).
Dec 31, 2025: Open-market purchase of RNXT shares (Form 4, code P).
Dec 30, 2025: Open-market purchase of RNXT shares (Form 4, code P).
Dec 16, 2025: Open-market purchase of RNXT shares (Form 4, code P).

Other insiders filing for RenovoRx, Inc. (RNXT)

Macfarlane K. Angela, Director
Spiegel Robert J., Director
RYAN UNA S, Director
Marton Laurence, Director
VOLL MARK, Chief Financial Officer
Bagai Shaun, Chief Executive Officer

How to read Form 4 transaction codes